
NASDAQConsumer DefensivePackaged Foods
最新数据
US$1.22
+US$0.08 · +7.02%
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
收盘时
US$1.22
+US$0.08 · +7.02%
盘后
US$1.22
US$0.00 · 0.00%
10月12日 19:30 ET
盘中时间采用ET。市场数据可能有所延迟。
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
日内区间
当前US$1.22
52周区间
当前US$1.22
盘中时间采用ET。市场数据可能有所延迟。
GoAI 评分
卖出
估值
47
合理估值
情绪
55
多空交织
风险
57
风险偏高
动量
27
动能减弱
完整 GoAI 研究
继续查看更深入的依据、催化因素和风险。
Natural Alternatives International, Inc. (NAII) is a company dedicated to the global development, manufacturing, and marketing of nutritional supplements, with operations spanning the United States, Europe, Asia, and other international territories. The company functions through two main divisions: Private-Label Contract Manufacturing and Patent and Trademark Licensing. Through its contract manufacturing segment, NAII provides tailored production services to businesses that market and distribute a range of health-related products, including vitamins, minerals, herbal remedies, and other dietary supplements. NAII also offers extensive strategic partnering support, which encompasses a broad spectrum of services. These include research and development (such as customized product formulation, scientific research, and proprietary ingredients), clinical studies, manufacturing, marketing assistance, adherence to international regulatory and labeling laws, global product registration, diverse packaging and labeling design, product testing, evaluation, and overall regulatory review. Furthermore, the company markets its own proprietary beta-alanine ingredient, available under the brand names CarnoSyn and SR CarnoSyn. NAII produces its supplements in various formats, including capsules, tablets, chewable wafers, and powders. Its private-label manufacturing clients primarily consist of companies distributing nutritional supplements through direct sales networks, direct-to-consumer e-commerce platforms, and traditional retail stores. Natural Alternatives International, Inc. was established in 1980 and is based in Carlsbad, California.
日内区间
当前US$1.22
52周区间
当前US$1.22
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目(USD) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 1.41亿 USD | 1.3亿 USD | 1.14亿 USD | 1.54亿 USD | 1.71亿 USD |
| 销货成本 | 1.34亿 USD | 1.21亿 USD | 1.07亿 USD | 1.36亿 USD | 1.4亿 USD |
| 毛利 | 783.5万 USD | 928.9万 USD | 686.5万 USD | 1815.8万 USD | 3050.9万 USD |
| 研究与开发 | 230万 USD | 180万 USD | 190万 USD | 210万 USD | 250万 USD |
| 销售、一般及管理费用 | 1729.6万 USD | 1654.9万 USD | 1539.9万 USD | 1486.9万 USD | 1695万 USD |
| 营业费用 | 1689.6万 USD | 1794.9万 USD | 1539.9万 USD | 1344.5万 USD | 1683万 USD |
| 利息收入 | 5万 USD | 16.8万 USD | 17.6万 USD | 3.3万 USD | — |
| 利息支出 | 118.6万 USD | 91.5万 USD | 36.1万 USD | 45.1万 USD | 8.3万 USD |
| 折旧和摊销 | 470.9万 USD | 456万 USD | 464.7万 USD | 425万 USD | 416.5万 USD |
| 营业利润 | −906.1万 USD | −866万 USD | −853.4万 USD | 471.3万 USD | 1367.9万 USD |
| 净利润 | −2069.5万 USD | −1357.5万 USD | −721.7万 USD | 252.2万 USD | 1071.2万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 1990年1月5日 | 1:50 | — | — |
已生效 1990年1月5日
1:50
报告持有此股票敞口的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI33.56万0.00%2.3万亿 USD0.03%US$381.57-0.10%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV15.85万0.00%268.09亿 USD0.33%US$37.98+0.08%
Vanguard Extended Market ETFVXF10.94万0.00%954亿 USD0.05%US$233.52-0.63%
U.S. Micro Cap Portfolio ETFDFMC7.52万0.00%75.58亿 USD0.43%US$57.70-0.20%
Dimensional - US Small Cap ETFDFAS4.75万0.00%338.69亿 USD0.31%US$78.17-0.23%
EA Bridgeway Omni Small-Cap Value ETFBSVO3万—23.91亿 USD0.45%US$28.50+0.46%
Dimensional - US Core Equity 2 ETFDFAC1.86万0.00%885.96亿 USD0.21%US$45.31-0.04%
U.S. Core Equity 1 Portfolio ETF Class SharesDCOR1.15万0.00%455.91亿 USD0.17%US$84.43-0.01%
Vanguard Morningstar Total Stock Market ETFVTI
U.S. Small Cap Value Portfolio ETF Class SharesDFSV
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Small Cap ETFDFAS
EA Bridgeway Omni Small-Cap Value ETFBSVO
Dimensional - US Core Equity 2 ETFDFAC
U.S. Core Equity 1 Portfolio ETF Class SharesDCORAI 生成内容及延迟市场数据仅供信息与教育用途,不构成投资建议。